NICE! Look what I found: WavSTAT mentioned in a RECENT

New Post Public Reply Private Reply Replies (0) Message Board
joey68
NICE! Look what I found:

WavSTAT mentioned in a RECENT filing for a Blue Cross/Blue Shield Company!

Quote:
At Anthem Blue Cross and Blue Shield we understand our health connects us to each other. What we all do impacts those around us. So Anthem is dedicated to delivering better care to our members, providing greater value to our customers and helping improve the health of our communities.


Main website:
https://www.anthem.com/health-insurance/home/overview

Check it out:
https://www.google.com/url?sa=t&rct=j&...2-YgRXWoLg

Look how recent this is:
Quote:
Current Effective Date: 01/01/2016
Status: Reviewed Last Review Date: 02/05/2015


WavSTAT™ Optical Biopsy System mentioned in the Index section.

Awesome quote:
Quote:
One device for fiberoptic analysis of colorectal polyps has received FDA pre-market approval (that is, the Optical Biopsy System™, SpectraScience , Minneapolis, MN). According to the FDA Summary of Safety and Effectiveness Data, this device should be used as an aide to lower gastrointestinal endoscopy as follows:

For the evaluation of polyps less than 1 cm in diameter that the physician has not already elected to remove. The device is only to be used in deciding whether such polyps should be removed (which includes submission for histological examination).

The FDA approval for this device was based in part on the results of a prospective study of 101 individuals undergoing colonoscopy that evaluated the sensitivity and specificity of the fiberoptic system compared to physician assessment alone . While fiberoptic analysis may identify additional adenomatous polyps that the physician considered to be hyperplastic based on visual assessment, it is difficult to determine the clinical significance of these findings. It is not clear how the physician decided to select additional polyps for fiberoptic analysis, or whether the same results could be obtained by simply randomly taking a biopsy of a subset of polyps that were considered hyperplastic on visual assessment.

SpectraSCIENCE Inc. (SCIE) Stock Research Links

SCIE Board Company Profile Buy Rating Time & Sales News Filings Financials
View My Board Here:
http://investorshangout.com/Joeys-Investment-Board-91611/


Invite Only

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.

Disclaimer:
As used herein, the terms "You" and "Your" shall mean you, individually, the reader, and each other party on whose behalf you may use the contained information at any time.
All references to "My", "I", and “The writer of the above post” shall refer to the creator of the username Joey68.

Do NOT invest unless you are prepared to sustain a total loss of the money you have invested plus any commission or other transaction charges.

There is a very high degree of risk involved in trading and investing. Past results are not indicative of future returns. I assume no responsibility for your trading and investment results. You should NOT rely on the information in the above post to make any decision or take any action.

ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are OPINION and NOT fact and are for entertainment purposes only. Do your own research and make your own decisions based on your own conclusions.
ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are NOT advice, and are NOT designed to substitute the expertise and judgment of a professional. It is your responsibility to seek investment advice during all stages of your investments. It is your responsibility to evaluate the accuracy, completeness and usefulness of the information in the above post.
I am NOT a professional.
I do NOT work for you.
My posts are NOT investment advice. I am not paid to post.
There is no correlation between the number of posts I write per day and your assumed success of a company.
It is NOT my responsibility to inform you of my own personal investment decisions.
It is NOT my responsibility to inform you when it is time for you to buy, hold, and/or sell a position.
I have no control over, and am not responsible for the actions of others who copy, store, edit, change, prepare any derivative work of or alter in any way any of the content provided in my posts.
Errors and Omissions expected. The writer of the above post accepts no liability or responsibility for any errors or omissions contained in the above post or contained within this Disclaimer.
The writer of the above post shall NOT accept any liability for the accuracy or completeness of the information contained in the above post, for any reliance placed by any person on the information contained in the above post, or for any damage or loss, however caused, in connection with the use or reliance on any information contained in the above post.
The above post may contain links to websites owned and operated by third parties. These links are provided for informational purposes only and are NOT endorsed by the writer of the above post. The writer of the above post has no control over the contents of any linked website and bears no responsibility for the accuracy, legality, or content of the external site or for that of subsequent links.
YOU ACCESS ALL LINKS ENTIRELY AT YOUR OWN RISK.
The writer of the above post makes no warranties or representations, express or implied about such linked websites, the third parties they are owned and operated by, or the information contained on these websites.
The writer of the above post accepts no liability for any damage or loss, however caused, in connection with the use of or reliance on any information, material, products, or services contained on or accessed through any such linked websites.

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 24

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 19

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 16

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 27

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 24

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 11

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 28

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading

Top 5 Most Recently Viewed Articles

Green Heron Partners Expands with Bison Infrastructure Services

Updated Category News Views 1098

Introduction to Bison Infrastructure Services Green Heron Partners, a notable private equity firm that focuses on operationally-driven lower middle-market investments, has recently established Bison Infrastructure Services. This new platform is dedicated to extending support services to owners and operators of vital water, utility, and civil infrastructure systems....

Continue Reading
Bank of America Experience Disruption: Customers Left Hanging

Updated Category News Views 264

Bank of America Customers Face Account Access Issues Recently, customers of Bank of America (NYSE: BAC) encountered major difficulties accessing their accounts, with many logging in only to see their balances displayed as zero. This troubling situation left many customers anxious and frustrated as they could not check their financial standing. Details Surrounding the...

Continue Reading
Important Updates on Napco Security Technologies, Inc. Lawsuit

Updated Category News Views 163

Napco Security Technologies, Inc. Lawsuit Overview Recently, significant news emerged regarding Napco Security Technologies, Inc. (NASDAQ: NSSC), highlighting concerns that investors need to be aware of. This notice informs shareholders about the current legal situation surrounding the company, emphasizing the necessity for investors to take action swiftly. Legal...

Continue Reading
Grvt Unveils Revolutionary On-Chain Investment Solutions

Updated Category News Views 125

Grvt Launches Innovative On-Chain Investment Marketplace Grvt has unveiled an exciting new product called "Strategies," which claims to be the first compliant, peer-to-peer, on-chain investment marketplace. This groundbreaking platform is designed to revolutionize how individuals and institutions invest in crypto markets. Building on Advanced Technology The marketplace is...

Continue Reading
Unity Bancorp Achieves Impressive $14.4 Million in Earnings

Updated Category News Views 135

Unity Bancorp's Quarterly Financial Performance Unity Bancorp, Inc. (NASDAQ: UNTY), the parent corporation of Unity Bank, achieved impressive net earnings of $14.4 million for the latest quarter, equating to $1.41 per diluted share. This marks a slight decline from the $16.5 million, or $1.61 per diluted share, reported in the previous quarter. Examining the figures for...

Continue Reading